v3.26.1
Issued share capital, share premium account and share options (Tables)
12 Months Ended
Mar. 31, 2026
Issued share capital, share premium account and share options  
Schedule of share capital

​

​

​

​

​

​

​

​

​

​

​

​

​

​

At March 31, 

​

​

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2024

​

​

​

 

€M

 

€M

 

€M

Authorized/Share Capital reorganization

​

​

​

​

​

​

​

​

1,550,000,000 ordinary equity shares of 0.600 euro cent each

​

​

 

9.3

 

9.3

 

9.3

1,368,000,000 'B' Shares of 0.050 euro cent each

​

​

 

0.7

 

0.7

 

0.7

1,368,000,000 Deferred shares of 0.050 euro cent each

​

​

 

0.7

 

0.7

 

0.7

​

​

​

 

10.7

 

10.7

​

10.7

Allotted, called-up and partly paid:

​

​

​

​

​

​

​

​

1,140,045,528 ordinary equity shares of 0.600 euro cent each

​

​

 

—

 

—

 

6.9

1,063,868,001 ordinary equity shares of 0.600 euro cent each

​

​

​

—

​

6.4

​

—

1,043,931,708 ordinary equity shares of 0.600 euro cent each

​

​

​

6.3

​

—

​

—

​

​

​

​

6.3

 

6.4

​

6.9

Schedule of share premium account

​

​

​

​

​

​

​

​

​

​

​

​

​

​

At March 31, 

​

  ​ ​ ​

​

​

2026

​

2025

  ​ ​ ​

2024

​

 

​

​

€M

 

€M

 

€M

Balance at beginning of year

 

​

​

1,421.6

 

1,404.3

 

1,379.9

Net proceeds from shares issued

​

​

​

3.2

​

4.9

​

16.4

Share premium receivable on shares issued

​

​

​

10.0

​

12.4

​

8.0

Balance at end of year

 

​

​

1,434.8

 

1,421.6

 

1,404.3

Schedule of share options outstanding

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Share

​

Weighted Avg.

​

  ​ ​ ​

​

​

​

​

Options

  ​ ​ ​

Exercise

​

  ​ ​ ​ ​

​

​

​

​

M

  ​ ​ ​ ​

Price (€)

Outstanding at March 31, 2023

 

​

​

​

​

18.7

​

11.24

Granted

 

​

​

​

​

—

​

—

Forfeited

​

​

​

​

​

(0.7)

​

11.12

Exercised

 

​

​

​

​

(1.4)

​

12.00

Outstanding at March 31, 2024

 

​

​

​

​

16.6

​

11.18

Granted

​

​

​

​

​

—

​

—

Forfeited

​

​

​

​

​

—

​

—

Exercised

​

​

​

​

​

(0.4)

​

11.45

Outstanding at March 31, 2025

 

​

​

​

​

16.2

​

11.12

Granted

​

​

​

​

​

—

​

—

Forfeited

​

​

​

​

​

—

​

—

Exercised

​

​

​

​

​

(0.3)

​

11.12

Outstanding at March 31, 2026

 

​

​

​

​

15.9

​

11.12

Schedule of range of exercise prices and weighted average remaining contractual life

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

No.

​

Remaining

​

​

​

​

Exercise

​

options

​

contractual

​

​

​

​

price

​

outstanding

​

life

​

​

​

​

€

​

M

  ​ ​ ​ ​

(years)

Vested

​

​

​

11.12

​

15.9

​

1.9

Weighted average

​

​

​

11.12

​

15.9

​

1.9